LEMAITRE VASCULAR, INC. Operating Lease Right-of-Use Assets
LEMAITRE VASCULAR, INC. (LMAT) had Operating Lease Right-of-Use Assets of $20.00 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-05
- 2026-06-30: Operating Lease, Right-of-Use Asset $20.00M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $19.83M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $15.76M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $16.04M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $20.00M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $19.83M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $15.76M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $16.04M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $16.52M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $16.23M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $16.77M 10-K · filed 2026-02-26 |
| 2024-09-30 | $17.20M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $17.29M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $17.80M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $18.03M 10-K · filed 2025-02-28 |
| 2023-09-30 | $15.85M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $15.80M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $15.53M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $15.63M 10-K · filed 2024-02-29 |
| 2022-09-30 | $15.79M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $16.29M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $14.69M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $15.07M 10-K · filed 2023-03-01 |
| 2021-09-30 | $15.66M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $16.24M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $15.48M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $16.07M 10-K · filed 2022-02-28 |
| 2020-09-30 | $16.37M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $16.73M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $14.88M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $15.21M 10-K · filed 2021-03-12 |
| 2019-09-30 | $6.01M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $6.43M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $6.27M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |